| Reduced Risk Status: |
|
| IPM Compatibility: |
PER REQUESTER: VERY GOOD FIT; THIS PRODUCT PROVIDES A NEW FRAC CODE AND PROVIDES EFFECTIVE, LONG-LASTING PROTECTION:08/22
|
| Reasons for need: |
STEMPHYLIUM VESICARIUM; CURRENTLY REGISTERED PRODUCTS INCLUDE PROTECTANTS AND STROBILURINS. NEW, MORE EFFECTIVE ACTIVES ARE NEEDED;
|
| Requesting State(s): |
MI:Hausbeck, M* ;
|
| PCR Use Pattern: |
MERIVON SC; DOSAGE-11 FL OZ/A; FOLIAR APPLICATION, 5 APPLICATIONS, RTI 14 DAYS, PHI 7 MONTHS
|
| EPA Default Residue Trials: |
2 5-2 10-3 11-2
|
| IR-4 Residue Trial Plan: |
|
| Residue Protocol Use Pattern: |
|
| Efficacy/Crop Safety (E/CS) Data Required: |
|
| E/CS Research Comments: |
PR# 13489 (MIRAVIS PRIME [PYDIFLUMETOFEN + FLUDIOXONIL]) E/CS WORK IS COVERED UNDER THIS PROJECT; PER 2023 PERFORMANCE PROTOCOL: TESTING MERIVON XEMIUM (FLUXAPYROXAD 21.26% + PYRACLOSTROBIN 21.26%) AND MIRAVIS PRIME (PYDIFLUMETOFEN 12.8% + FLUDIOXONIL 21.4%) FOR PURPLE SPOT CONTROL ON ASPARAGUS FERNS; MAKE 3 FOLIAR APPLIC OF MERIVON XEMIUM TREATMENTS (2 RATES, WITH/WITHOUT NIS, 7-DAY INTERVAL) VS 2 APPLIC OF MIRAVIS PRIME + NIS (14-DAY INTERVAL), ALL IN 20-60 GPA; COMPARE VS A CHLOROTHALONIL STANDARD; BEGIN SPRAYS WHEN WEATHER IS FAVORABLE FOR INFECTION OR AT FIRST SIGNS OF DISEASE; EVALUATE EFFICACY AND CROP SAFETY; SEE PROTOCOL FOR MUCH MORE TREATMENT DETAIL;
|
| Label Use Pattern Submitted To EPA: |
|
| EPA PIF Status: |
YELLOW 08/23
|
| EPA Status: |
|
| EPA PRIA Date: |
|
| MRID: |
|
| Comments: |
ORIGINALLY, POTENTIAL: E/CS DATA BEFORE APPROVAL FOR RESIDUE, CHANGED TO E/CS DATA ONGOING: 03/23, JPB; THE PERFORMANCE PROTOCOL FOR THIS PR# IS ASSOCIATED WITH PR# 13489 RESULTS FROM TEH PROTOCOL WILL BE POSTED TO BOTH PR#'S: 03/23, JPB; YELLOW 08/23; Two Performance trials completed 2023, awaiting decisions for moving forward with Residue studies from MFG.: 01/24, JPB;
|
| International Status: |
|
| Archive Location: |
|
| QA Archive: |
|